Celestica (CLS) Ascends While Market Falls: Some Facts to Note

Celestica rose 1.61% to $361.84 despite a 0.76% S&P 500 decline and is up 16.04% over the past month, outperforming both its technology sector and the broader index. Consensus forecasts call for quarterly EPS of $3.01 (+90.51% year over year) on $5.4 billion of revenue (+69.1%), with full-year EPS and revenue expected to rise 87.11% and 64.27%, respectively. The company retains a Zacks Rank #1, although its 31.45x forward P/E is above the industry's 24.45x average.

Analysis

CLS is priced for continued upside to a growth cycle whose visibility is concentrated in AI/data-center hardware programs. With estimates unchanged despite the recent run, the next earnings event must deliver more than a beat: investors will require raised forward revenue, evidence that higher-value hardware mix is sustaining gross margins, and order/backlog visibility extending beyond a single customer or platform cycle. A merely in-line guide could trigger a sharp de-rating because the stock already trades at a material premium to EMS peers.

The more attractive second-order read-through is that hyperscaler infrastructure spending is shifting value from commodity assembly toward complex system integration, testing and supply-chain orchestration. That favors CLS relative to broad EMS peers such as Jabil (JBL), Sanmina (SANM), and Flex (FLEX), but also makes it more exposed to customer concentration, component availability, and any pause in AI rack deployments. Over 6-18 months, sustained demand could support elevated returns on capital; conversely, a normalization of AI capex turns operating leverage negative faster than the current multiple implies.

Consensus appears to treat the earnings-growth trajectory as a clean extension. The contrarian risk is not a weak reported quarter but a shift in management commentary from capacity constraint to demand normalization, or margins being diluted as program mix broadens. The key falsifiers are a forward revenue-guide increase, gross-margin resilience, and backlog/customer-concentration disclosures; without those, the recent price strength is momentum rather than a new fundamental signal.

Key Decisions for Investors

• Do not chase CLS ahead of earnings after the recent momentum move; initiate only on a post-results pullback if management raises forward revenue expectations and holds gross-margin guidance. Target a 3-6 month position with a 15-20% upside objective; exit if forward guidance is merely maintained or gross margin declines materially.
• For AI-infrastructure exposure, use a relative-value basket: long CLS versus short FLEX or SANM over 3-6 months only if CLS demonstrates superior margin/backlog conversion at earnings. Size modestly because all three retain cyclicality to enterprise and communications demand; cover the short leg if peer guidance improves faster than CLS.
• Buy near-dated downside protection rather than outright calls if retaining CLS through earnings: a put spread expiring 1-2 months after results limits the risk of premium-multiple compression while preserving participation in a guide-driven upside surprise.
• Set an earnings checklist before adding: forward revenue guide, gross-margin outlook, backlog duration, top-customer concentration, and working-capital/cash-conversion trends. Treat any deterioration in two or more metrics as a signal to reduce exposure rather than average down.